|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03259282 |
|
Date of registration:
|
21/08/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis
GAMES |
|
Scientific title:
|
Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis |
|
Date of first enrolment:
|
March 7, 2017 |
|
Target sample size:
|
78 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03259282 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients newly diagnosed with sarcoidosis
Exclusion Criteria:
- Comorbidity responsible for a change in the level of gamma globulin
- Other etiology of granulomatosis
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Sarcoidosis
|
|
Intervention(s)
|
|
Biological: Analysis of gamma globulin
|
|
Primary Outcome(s)
|
|
Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on disease activity
[Time Frame: Day 1]
|
|
Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on the course of the disease
[Time Frame: Day 1]
|
|
Secondary ID(s)
|
|
35RC16_3046_GAMES
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|